Background and aims The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guideline recommends risk stratification for chronic kidney disease (CKD) management; however, patients within the same KDIGO category may still experience heterogeneous outcomes. Hypertension and type 2 diabetes mellitus (T2DM) are predominant causes of CKD, and hepatic fibrosis is highly prevalent in this population, but […]
Read MoreAuthor: sugaradmin
Want to Live a Longer, Healthier Life? Your Midlife Fitness Matters
Share on PinterestA recent study found that your midlife fitness can affect your life span and health span. Image Credit: Emilija Manevska/Getty Images Recent research has shown that adults with higher levels of midlife cardiorespiratory fitness may live longer, healthier lives. The study found that people with higher fitness levels not only lived longer but […]
Read MoreCognitive skills in children and adolescents with type 1 diabetes: a scoping review and meta-analysis
Type 1 diabetes (T1D) complications may impair cognitive development, but evidence on cognitive skills in children and adolescents with T1D is inconsistent. This study aimed to document measures and outcomes used to assess cognitive skills in children with T1D and to examine the relationship between T1D and cognitive skills. A systematic literature search was conducted […]
Read More
FDA to Fast-Track Psychedelic Drugs for PTSD: What This Means
Share on PinterestThe Trump administration has directed the FDA to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental health disorders. farmer images/Getty Images A sweeping executive order aims to fast-track psychedelic therapies, putting drugs like ibogaine in the national spotlight. The policy expands research funding, accelerates FDA review pathways, and opens access […]
Read More
Ozempic Preserves Muscle Mass Better Than Mounjaro
Share on PinterestResearch shows that Ozempic may preserve lean body mass better than Mounjaro. Image Credit: Iuliia Burmistrova/Getty Images A recent study found that semaglutide medications, such as Ozempic, may better preserve lean body mass than tirzepatide medications, such as Mounjaro. This may be due in part to tirzepatide leading to more significant weight loss. […]
Read More
Olympic Track and Field Star Allyson Felix Talks Rest and Recovery
Track and field star Allyson Felix shares rest and recovery tips and explains why motherhood inspired her to advocate for paid leave. Share on PinterestAllyson Felix, mom of two and the most decorated track and field athlete in U.S. history, understands the importance of rest and recovery. Photography courtesy of Allyson Felix When it comes […]
Read More
Fructose in Ultra-Processed Foods May Raise Metabolic Disease
Share on PinterestResearch shows that fructose, especially in ultra-processed foods, may increase the risk of metabolic diseases. Image Credit: Ivan Solis/Stocksy A recent study has shown that fructose plays a role in driving disease. The research shows that the effects fructose can have on the body may be associated with metabolic syndrome. Understanding the effects […]
Read More
Trump Reclassifies Marijuana as Less Dangerous in Major Policy Shift
Share on PinterestFlowers, also known as buds, grow at the top of a mature marijuana plant on a farm owned and operated by Qualla Enterprises, LLC in Cherokee, NC. Image credit: Charlotte Observer/Getty Images An executive order signed by the Trump administration reclassifies medical cannabis as a less dangerous drug. Although this does not legalize […]
Read More
Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62%
Share on PinterestGLP-1 drugs containing tirzepatide significantly reduce cardiovascular risks in people with serious heart conditions. Indranil MUKHERJEE / AFP via Getty Images GLP-1 weight loss medications containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with serious heart conditions, according to new research. Experts say the heart health benefits are produced by […]
Read More
FDA Issues Nationwide Recall of ‘Extended Release’ Xanax for Anxiety
Share on PinterestThe FDA issued a nationwide recall of Xanax XR for failing to meet dissolution specifications. BSIP/Universal Images Group via Getty Images The FDA has issued a report regarding the voluntary recall of a single lot of Xanax XR. Viatris has recalled 3-milligram tablets in 60-tablet bottles with the lot number 8177156. The company […]
Read More